home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Pharmacogenetics and Pharmacogenomics: Adverse Drug Reactions

 
  March 14, 2008  
     
 
European Science Foundation / University of Barcelona, Hotel Eden Roc, Sant Feliu de Guixols
June 27 - July 02, 2008


Adverse drug reactions are a major problem for healthcare services, the pharmaceutical industry and regulators.  This has been highlighted recently with some high-profile drug withdrawals and regulatory decisions. There is an urgent need to develop strategies to reduce the burden of adverse drug reaction – this needs to apply to both drug development (to reduce the rate of attrition) and during clinical use (to reduce patient morbidity, mortality, costs to healthcare, and drug withdrawals). Although there are many factors involved in the causation of adverse drug reactions, and hence in the processes that will be needed to improve drug safety, pharmacogenomics is an important technology that could provide major benefits. 

The promise of pharmacogenomics in preventing adverse drug reactions has already been witnessed through studies on glucose-6-phosphate dehydrogenase deficiency and haemolysis associated with antimalarials, TPMT testing and 6-mercaptopurine toxicity and HLA-B*5701 genotyping and abacavir hypersensitivity. The ESF-UB Conference on Pharmacogenomics will concentrate on adverse drug reactions this year, providing an interactive forum for both senior and junior researchers to learn about the latest developments in safety pharmacogenomics.

 
 
Organized by: Professor Munir Pirmohamed
Invited Speakers:

For information about the invited speakers: click here.

 

 

 
Deadline for Abstracts: 2008-03-30
 
Registration:

For online registration: click here.  

E-mail: corefice@esf.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.